• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARROW INTERNATIONAL INC. FIBEROPTIX ULTRA 8 IAB: 8FR 40CC; SYSTEM, BALLOON, INTRA-AORTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARROW INTERNATIONAL INC. FIBEROPTIX ULTRA 8 IAB: 8FR 40CC; SYSTEM, BALLOON, INTRA-AORTIC Back to Search Results
Catalog Number IAB-05840-LWS
Device Problem Occlusion Within Device (1423)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 01/05/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Other remarks: for related complaint see mdr #1219856-2018-00023 and (b)(4).
 
Event Description
It was reported by the rn that she has a patient that transferred from an outside hospital with an intra-aortic balloon pump (iabp).The rn reported that the systolic and diastolic pressures were the same.They were using a fiber-optic catheter and the light bulb was green.The clinical support specialist (css) had the rn switch to transducer and level and zero the transducer.The css talked her through the calibration procedure, and the hemodynamics did not change.A cardiology fellow came to the bedside and attempted to draw back on the catheter and stated he could not get anything back.The css told him that there must be a clot on the end of the catheter and the fiber optic sensor (fos) may be covered by the clot as well.The css told the md that they could place an arterial line to use for monitoring the timing and patient.The cardiology fellow did not want to place another line and was going to call the attending md.The css explained that the clot could have started to form at insertion.The md stated the patient was stable.The iab was taken out the following day.There was no reported patient death, serious injury or patient complications.No medical intervention was required and no delay or interruption in therapy.
 
Manufacturer Narrative
(b)(4).Teleflex received the device for investigation.The reported complaint of central lumen occluded is not able to be confirmed.The cause of the complaint was unable to be determined due to the returned state of the device.Due to the damage, the device was unable to be functionally tested.The root cause of the complaint is undetermined.A device history record (dhr) review was conducted for the lot number with no relevant findings.The device passed all manufacturing specifications prior to release.This will be monitored for any developing trends.No further action required at this time.Other remarks: for related complaint see mdr #1219856-2018-00023 and (b)(4).
 
Event Description
It was reported by the rn that she has a patient that transferred from an outside hospital with an intra-aortic balloon pump (iabp).The rn reported that the systolic and diastolic pressures were the same.They were using a fiber-optic catheter and the light bulb was green.The clinical support specialist (css) had the rn switch to transducer and level and zero the transducer.The css talked her through the calibration procedure, and the hemodynamics did not change.A cardiology fellow came to the bedside and attempted to draw back on the catheter and stated he could not get anything back.The css told him that there must be a clot on the end of the catheter and the fiber optic sensor (fos) may be covered by the clot as well.The css told the md that they could place an arterial line to use for monitoring the timing and patient.The cardiology fellow did not want to place another line and was going to call the attending md.The css explained that the clot could have started to form at insertion.The md stated the patient was stable.The iab was taken out the following day.There was no reported patient death, serious injury or patient complications.No medical intervention was required and no delay or interruption in therapy.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FIBEROPTIX ULTRA 8 IAB: 8FR 40CC
Type of Device
SYSTEM, BALLOON, INTRA-AORTIC
Manufacturer (Section D)
ARROW INTERNATIONAL INC.
reading PA
Manufacturer (Section G)
ARROW INTERNATIONAL INC.
16 elizabeth drive
chelmsford MA 01824
Manufacturer Contact
carmen sherman
16 elizabeth drive
chelmsford, MA 01824
9782505100
MDR Report Key7228887
MDR Text Key98677148
Report Number1219856-2018-00027
Device Sequence Number1
Product Code DSP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K021462
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 01/05/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/30/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/31/2019
Device Catalogue NumberIAB-05840-LWS
Device Lot Number18F17F0002
Other Device ID Number00801902007247
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/26/2018
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/01/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/02/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-